These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6588736)

  • 1. Case-control studies in the assessment of drug safety.
    Vessey MP
    Acta Med Scand Suppl; 1984; 683():29-33. PubMed ID: 6588736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug utilization and morbidity statistics for the evaluation of drug safety in Sweden.
    Wiholm BE; Westerholm B
    Acta Med Scand Suppl; 1984; 683():107-17. PubMed ID: 6430038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-population studies in pharmacoepidemiology.
    Capellà D; Pedrós C; Vidal X; Laporte JR
    Drug Saf; 2002; 25(1):7-19. PubMed ID: 11820909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiological evaluation of drugs.
    Shapiro S
    Acta Med Scand Suppl; 1984; 683():23-7. PubMed ID: 6588735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review on the application of pharmacoepidemiology in assessing prescription drug-related adverse events in pediatrics.
    Luo X; Cappelleri JC; Frush K
    Curr Med Res Opin; 2007 May; 23(5):1015-24. PubMed ID: 17526119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure opportunity in epidemiologic studies.
    Schlesselman JJ; Stadel BV
    Am J Epidemiol; 1987 Feb; 125(2):174-8. PubMed ID: 3812426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and analysis of drug safety studies, with special reference to sporadic drug use and acute adverse reactions.
    Feldmann U
    J Clin Epidemiol; 1993 Mar; 46(3):237-44. PubMed ID: 8455048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence.
    Baldacci S; Gorini F; Santoro M; Pierini A; Minichilli F; Bianchi F
    Epidemiol Prev; 2018; 42(3-4 Suppl 1):1-34. PubMed ID: 30066535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological and conceptual issues regarding occupational psychosocial coronary heart disease epidemiology.
    Burr H; Formazin M; Pohrt A
    Scand J Work Environ Health; 2016 May; 42(3):251-5. PubMed ID: 26960179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple self-controlled case series for large-scale longitudinal observational databases.
    Simpson SE; Madigan D; Zorych I; Schuemie MJ; Ryan PB; Suchard MA
    Biometrics; 2013 Dec; 69(4):893-902. PubMed ID: 24117144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term exposure to air pollution on hospital admissions of young children for acute lower respiratory infections in Ho Chi Minh City, Vietnam.
    ; Le TG; Ngo L; Mehta S; Do VD; Thach TQ; Vu XD; Nguyen DT; Cohen A
    Res Rep Health Eff Inst; 2012 Jun; (169):5-72; discussion 73-83. PubMed ID: 22849236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug Reactions.
    Backenroth D; Chase H; Friedman C; Wei Y
    PLoS One; 2016; 11(10):e0164304. PubMed ID: 27716785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series.
    Schuemie MJ; Trifirò G; Coloma PM; Ryan PB; Madigan D
    Stat Methods Med Res; 2016 Dec; 25(6):2577-2592. PubMed ID: 24685766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic studies: pitfalls in interpretation.
    Westhoff CL
    Dialogues Contracept; 1995; 4(5):5-6, 8. PubMed ID: 12288680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case-time-control design.
    Suissa S
    Epidemiology; 1995 May; 6(3):248-53. PubMed ID: 7619931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rationale for a post-marketing surveillance.
    Westerholm B
    Hum Reprod; 1987 Jan; 2(1):41-4. PubMed ID: 3571446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions: the need for detection and control.
    Cluff LE
    Am J Epidemiol; 1971 Nov; 94(5):405-8. PubMed ID: 5120538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.